XASXAJX
Market cap11mUSD
Jan 08, Last price
0.01AUD
1D
-7.69%
1Q
0.00%
Jan 2017
-97.43%
Name
Alexium International Group Ltd
Chart & Performance
Profile
Alexium International Group Limited manufactures and sells phase-change material (PCM) and other specialty textile solutions in the United States. It offers thermal regulation solutions, such as Alexicool, a PCM chemical finish for fabrics; Biocool, a natural and biobased PCM cooling for textile and foam bedding applications; and Eclipsys, a perpetual cooling technology that enhance the cooling experience for textile and foam bedding systems. The company also provides flame retardant solutions, such as Alexiflam, a flame-retardant treatment for cotton, linen, and other cellulosic textiles, as well as mattress applications. It serves bedding, military, and workwear markets. The company was incorporated in 1994 and is based in Greer, South Carolina.
IPO date
Dec 22, 1999
Employees
319
Domiciled in
AU
Incorporated in
AU
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | 2016‑06 | 2015‑06 | |
Income | ||||||||||
Revenues | 5,893 -18.04% | 7,190 -11.69% | 8,141 11.75% | |||||||
Cost of revenue | 6,905 | 9,036 | 11,128 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | (1,012) | (1,847) | (2,987) | |||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | (1,012) | (1,847) | (2,987) | |||||||
Net income | (2,761) | |||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | 2,813 | (4) | ||||||||
BB yield | -29.66% | 0.03% | ||||||||
Debt | ||||||||||
Debt current | 526 | 298 | 178 | |||||||
Long-term debt | 1,044 | 5,123 | 4,390 | |||||||
Deferred revenue | ||||||||||
Other long-term liabilities | (1) | 674 | 182 | |||||||
Net debt | (499) | 4,891 | 3,521 | |||||||
Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | (156) | |||||||||
Cash from financing activities | 2,911 | 993 | 74 | |||||||
FCF | (945) | (489) | (3,172) | |||||||
Balance | ||||||||||
Cash | 2,053 | 512 | 1,023 | |||||||
Long term investments | 17 | 18 | 24 | |||||||
Excess cash | 1,775 | 170 | 640 | |||||||
Stockholders' equity | 3,302 | (9) | 2,760 | |||||||
Invested Capital | 2,497 | 3,738 | 4,827 | |||||||
ROIC | ||||||||||
ROCE | ||||||||||
EV | ||||||||||
Common stock shares outstanding | 790,457 | 646,906 | 642,892 | |||||||
Price | 0.01 -7.69% | 0.01 -45.83% | 0.02 -51.02% | |||||||
Market cap | 9,485 12.79% | 8,410 -45.50% | 15,429 -50.59% | |||||||
EV | 8,986 | 13,301 | 18,950 | |||||||
EBITDA | (1,012) | (1,485) | (2,618) | |||||||
EV/EBITDA | ||||||||||
Interest | 991 | 905 | 776 | |||||||
Interest/NOPBT |